Back to
BlackRock, Inc.
SNOA
8 quarters
Position history for
BlackRock, Inc.'s holdings in Sonoma Pharmaceuticals, Inc.
Yes. BlackRock holds 113 shares of SNOA (Sonoma Pharmaceuticals), worth $139, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. BlackRock has held SNOA in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$139
Current Shares
113
Total Value Change
-$208
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SNOA: Vanguard Group Inc., Geode Capital Management, LLC, Renaissance Technologies LLC